Neurotrophins prevent HIV Tat‐induced neuronal apoptosis via a nuclear factor‐κB (NF‐κB)‐dependent mechanism
HIV‐1 associated dementia is thought to be caused by neuronal damage and death in response to the production of soluble neurotoxic factors by virally infected mononuclear phagocytes. These neurotoxins include HIV‐1 Tat. The ability of neurotrophins to promote cell survival prompted us to examine whe...
Saved in:
Published in | Journal of neurochemistry Vol. 78; no. 4; pp. 874 - 889 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Science Ltd
01.08.2001
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | HIV‐1 associated dementia is thought to be caused by neuronal damage and death in response to the production of soluble neurotoxic factors by virally infected mononuclear phagocytes. These neurotoxins include HIV‐1 Tat. The ability of neurotrophins to promote cell survival prompted us to examine whether neurotrophins might also be capable of opposing the pro‐apoptotic effects of Tat. Here, we show that Tat‐induced neuronal apoptosis in primary cultures of rat cerebellar granule cells and in neuronally differentiated human SK‐N‐MC cells is profoundly inhibited by brain‐derived neurotrophic factor, nerve growth factor and activity‐dependent neurotrophic factor nonamer peptide. These neurotrophins activated the transcription factor NF‐κB, and inhibition of NF‐κB activation using a super‐repressor IκB‐α mutant was found to block the survival‐promoting activity of the neurotrophins. Reporter gene assays and immunoblot experiments revealed that the neurotrophins also up‐regulated the expression of Bcl‐2, at both the transcriptional and protein levels. Overexpression of the super‐repressor IκB‐α mutant prevented this induction of Bcl‐2 expression. Moreover, overexpression of either Bcl‐2, alone, or the RelA subunit of NF‐κB, alone, protected neurons from Tat‐induced apoptosis. These findings suggest that the activation of NF‐κB by neurotrophic factors may promote survival of neurons exposed to Tat, via regulation of anti‐apoptotic genes including Bcl‐2. |
---|---|
AbstractList | HIV‐1 associated dementia is thought to be caused by neuronal damage and death in response to the production of soluble neurotoxic factors by virally infected mononuclear phagocytes. These neurotoxins include HIV‐1 Tat. The ability of neurotrophins to promote cell survival prompted us to examine whether neurotrophins might also be capable of opposing the pro‐apoptotic effects of Tat. Here, we show that Tat‐induced neuronal apoptosis in primary cultures of rat cerebellar granule cells and in neuronally differentiated human SK‐N‐MC cells is profoundly inhibited by brain‐derived neurotrophic factor, nerve growth factor and activity‐dependent neurotrophic factor nonamer peptide. These neurotrophins activated the transcription factor NF‐κB, and inhibition of NF‐κB activation using a super‐repressor IκB‐α mutant was found to block the survival‐promoting activity of the neurotrophins. Reporter gene assays and immunoblot experiments revealed that the neurotrophins also up‐regulated the expression of Bcl‐2, at both the transcriptional and protein levels. Overexpression of the super‐repressor IκB‐α mutant prevented this induction of Bcl‐2 expression. Moreover, overexpression of either Bcl‐2, alone, or the RelA subunit of NF‐κB, alone, protected neurons from Tat‐induced apoptosis. These findings suggest that the activation of NF‐κB by neurotrophic factors may promote survival of neurons exposed to Tat, via regulation of anti‐apoptotic genes including Bcl‐2. HIV-1 associated dementia is thought to be caused by neuronal damage and death in response to the production of soluble neurotoxic factors by virally infected mononuclear phagocytes. These neurotoxins include HIV-1 Tat. The ability of neurotrophins to promote cell survival prompted us to examine whether neurotrophins might also be capable of opposing the pro-apoptotic effects of Tat. Here, we show that Tat-induced neuronal apoptosis in primary cultures of rat cerebellar granule cells and in neuronally differentiated human SK-N-MC cells is profoundly inhibited by brain-derived neurotrophic factor, nerve growth factor and activity-dependent neurotrophic factor nonamer peptide. These neurotrophins activated the transcription factor NF- Kappa B, and inhibition of NF- Kappa B activation using a super-repressor I Kappa B- alpha mutant was found to block the survival-promoting activity of the neurotrophins. Reporter gene assays and immunoblot experiments revealed that the neurotrophins also up-regulated the expression of Bcl-2, at both the transcriptional and protein levels. Overexpression of the super-repressor I Kappa B- alpha mutant prevented this induction of Bcl-2 expression. Moreover, overexpression of either Bcl-2, alone, or the RelA subunit of NF- Kappa B, alone, protected neurons from Tat-induced apoptosis. These findings suggest that the activation of NF- Kappa B by neurotrophic factors may promote survival of neurons exposed to Tat, via regulation of anti-apoptotic genes including Bcl-2. |
Author | Dimitri, Christopher A. Dewhurst, Stephen Ramirez, Servio H. Gelbard, Harris A. Maggirwar, Sanjay B. Sanchez, Joseph F. |
Author_xml | – sequence: 1 givenname: Servio H. surname: Ramirez fullname: Ramirez, Servio H. – sequence: 2 givenname: Joseph F. surname: Sanchez fullname: Sanchez, Joseph F. – sequence: 3 givenname: Christopher A. surname: Dimitri fullname: Dimitri, Christopher A. – sequence: 4 givenname: Harris A. surname: Gelbard fullname: Gelbard, Harris A. – sequence: 5 givenname: Stephen surname: Dewhurst fullname: Dewhurst, Stephen – sequence: 6 givenname: Sanjay B. surname: Maggirwar fullname: Maggirwar, Sanjay B. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14120672$$DView record in Pascal Francis |
BookMark | eNqNkEFO3DAUhi0EEgPtHbyhahcJduJJxlI37agUKjRsKFvrxX4WHmXs1E4G2PUInIdD9BA9SRMGlS2r92R___-k74js--CREMpZzpmoTtc5FzXPBJ_LvGCM52x8rfP7PTL7_7FPZowVRVYyURySo5TWI1iJis_IdoVDDH0M3a3ziXYRt-h7en5xQ6-h__v70XkzaDTUT5yHlkIXuj4kl-jWAQXqB90iRGpB9yGOiT9PX-nH1dlu-zQOgx16M9VuUN-Cd2nzjhxYaBO-f5nH5OfZt-vleXZ59f1i-eUy06LgdSYtMzXnwiBq3aC0eiFRN1UjGlnays654VaDNgANLBjDprQGjZTzskAjdHlMPux6uxh-DZh6tXFJY9uCxzAkxRdc1qyWI7jYgTqGlCJa1UW3gfigOFOTaLVWk081-VSTaPUsWt2P0ZOXG5A0tDaC1y695gUvWFUXI_d5x925Fh_e3K9-rJbjUv4DX3abTA |
CODEN | JONRA9 |
CitedBy_id | crossref_primary_10_1016_j_exphem_2014_10_004 crossref_primary_10_1111_j_1460_9568_2004_03493_x crossref_primary_10_1007_s11481_015_9645_6 crossref_primary_10_1016_j_nbd_2005_07_018 crossref_primary_10_4049_jimmunol_177_1_702 crossref_primary_10_1074_jbc_M408643200 crossref_primary_10_1016_j_micinf_2005_11_014 crossref_primary_10_1007_s11010_011_0815_4 crossref_primary_10_1016_S1000_1948_07_60020_3 crossref_primary_10_1074_jbc_M109_034504 crossref_primary_10_1007_s11481_011_9325_0 crossref_primary_10_1089_aid_2006_22_248 crossref_primary_10_1007_s11481_013_9520_2 crossref_primary_10_1038_s42003_022_03177_3 crossref_primary_10_1523_JNEUROSCI_2781_08_2009 crossref_primary_10_1007_BF03033824 crossref_primary_10_1098_rsob_200286 crossref_primary_10_1002_glia_23904 crossref_primary_10_1007_s13365_012_0084_3 crossref_primary_10_1002_ddr_10103 crossref_primary_10_1007_s12035_017_0450_5 crossref_primary_10_1007_BF03033829 crossref_primary_10_1007_s11481_011_9295_2 crossref_primary_10_1016_j_expneurol_2015_09_012 crossref_primary_10_1002_jgm_825 crossref_primary_10_1515_REVNEURO_2010_21_4_299 crossref_primary_10_1007_s12035_012_8320_7 crossref_primary_10_1371_journal_pone_0024412 crossref_primary_10_1016_j_isci_2023_106005 crossref_primary_10_1128_MCB_23_13_4649_4662_2003 crossref_primary_10_1002_jnr_20780 crossref_primary_10_1007_s11481_006_9017_3 crossref_primary_10_1523_JNEUROSCI_1042_10_2010 crossref_primary_10_1182_blood_2010_05_287193 crossref_primary_10_1097_QAI_0000000000002831 crossref_primary_10_1038_sj_onc_1207828 crossref_primary_10_1111_j_1460_9568_2006_04813_x crossref_primary_10_1097_00126334_200312150_00004 crossref_primary_10_1007_s12031_014_0273_z crossref_primary_10_1007_s11060_004_3116_x crossref_primary_10_1007_s11481_021_10002_x crossref_primary_10_1016_j_addr_2004_10_010 crossref_primary_10_1371_journal_pone_0016148 crossref_primary_10_1038_sj_npp_1301615 crossref_primary_10_1007_BF03033447 crossref_primary_10_1124_mol_106_031427 crossref_primary_10_1179_1743132814Y_0000000333 crossref_primary_10_2217_fvl_12_57 crossref_primary_10_1007_s12640_009_9047_8 crossref_primary_10_1016_j_mcn_2008_04_001 crossref_primary_10_1007_BF03256266 crossref_primary_10_1124_mol_63_6_1238 crossref_primary_10_1300_J128v02n03_01 crossref_primary_10_1007_s00125_019_4888_z crossref_primary_10_1038_sj_cdd_4401577 crossref_primary_10_1111_j_1749_6632_2005_tb00032_x crossref_primary_10_4049_jimmunol_178_5_3226 crossref_primary_10_1111_joim_12050 crossref_primary_10_1111_j_1460_9568_2007_05506_x crossref_primary_10_1007_s13365_021_00956_2 crossref_primary_10_1002_jnr_21492 crossref_primary_10_1080_08830180490265538 crossref_primary_10_1007_BF03033818 crossref_primary_10_1007_BF03033819 crossref_primary_10_2353_ajpath_2007_060391 |
Cites_doi | 10.1016/S0166-2236(96)01049-1 10.1002/ana.410370314 10.1073/pnas.91.8.3309 10.1074/jbc.M010499200 10.1126/science.8096091 10.1046/j.1471-4159.2000.0750101.x 10.4049/jimmunol.165.4.1743 10.1083/jcb.148.2.325 10.1046/j.1471-4159.2001.00089.x 10.1093/nar/17.15.6419 10.1016/0092-8674(93)90230-N 10.1093/nar/27.10.2086 10.1126/science.272.5261.542 10.1046/j.1471-4159.1999.0731363.x 10.1002/(SICI)1097-4547(19970115)47:2<155::AID-JNR4>3.0.CO;2-E 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.0.CO;2-3 10.1074/jbc.275.11.7558 10.1002/(SICI)1097-4547(19981115)54:4<465::AID-JNR4>3.0.CO;2-T 10.1146/annurev.immunol.16.1.395 10.1046/j.1471-4159.2000.0751377.x 10.1016/0896-6273(94)90266-6 10.1074/jbc.274.32.22569 10.1074/jbc.273.28.17852 10.1083/jcb.139.3.809 10.1016/S0736-5748(00)00004-6 10.1073/pnas.95.5.2509 10.1046/j.1471-4159.1999.0732341.x 10.1126/science.7701324 10.1046/j.1471-4159.2002.00831.x 10.1126/science.275.5303.1129 10.1523/JNEUROSCI.18-08-02933.1998 10.1523/JNEUROSCI.18-24-10356.1998 10.1126/science.286.5448.2358 10.1128/MCB.15.5.2359 10.1002/j.1460-2075.1995.tb07287.x 10.1046/j.1471-4159.2000.740527.x 10.1074/jbc.274.14.9828 10.1046/j.1471-4159.1999.0730578.x 10.1074/jbc.274.13.8531 10.1126/science.281.5383.1680 10.1006/mcne.1999.0770 10.1006/exnr.1998.6958 10.1002/1521-4141(200002)30:2<661::AID-IMMU661>3.0.CO;2-L 10.1016/0304-3940(95)11603-T 10.1038/82199 10.1146/annurev.neuro.20.1.245 10.1038/375497a0 10.1002/ana.410320104 10.1097/00001756-199709080-00026 10.1097/00005072-199311000-00002 10.1126/science.281.5379.998 10.1126/science.1411528 10.1523/JNEUROSCI.19-20-08856.1999 10.1002/jnr.490420105 10.1074/jbc.C000507200 10.1006/viro.1994.1026 10.1126/science.275.5303.1132 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.0.CO;2-T 10.1146/annurev.immunol.16.1.225 10.1128/MCB.19.9.5923 10.1002/ana.410190603 10.1016/S0306-4522(97)00174-7 10.1126/science.274.5288.782 10.1016/S0092-8674(00)80595-4 10.1006/viro.1994.1673 10.1126/science.270.5240.1326 10.1055/s-2008-1040831 10.1523/JNEUROSCI.17-11-04201.1997 |
ContentType | Journal Article |
Copyright | 2002 INIST-CNRS |
Copyright_xml | – notice: 2002 INIST-CNRS |
DBID | IQODW AAYXX CITATION 7TK 7U9 H94 |
DOI | 10.1046/j.1471-4159.2001.00467.x |
DatabaseName | Pascal-Francis CrossRef Neurosciences Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef AIDS and Cancer Research Abstracts Neurosciences Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | CrossRef AIDS and Cancer Research Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1471-4159 |
EndPage | 889 |
ExternalDocumentID | 10_1046_j_1471_4159_2001_00467_x 14120672 JNC467 |
Genre | article |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAYJJ AAZKR ABCQN ABCUV ABEML ABIVO ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GAKWD GODZA GX1 H.X HF~ HGLYW HH5 HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TWZ UB1 V8K VH1 W8V W99 WBKPD WIH WIJ WIK WIN WNSPC WOHZO WOW WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XJT YFH YNH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT 08R AAJUZ AAVGM ABCVL ABFLS ABHUG ABPTK ABWRO ACSMX ACXME ADAWD ADDAD ADGIM AFVGU AGJLS IQODW PQEST UMP ZA5 AAYXX CITATION 7TK 7U9 H94 |
ID | FETCH-LOGICAL-c4217-9f0d7114deeccbe9fc89ecb6b4b93f6f51d1fcacdaaba800eb3fded99532ed4c3 |
IEDL.DBID | DR2 |
ISSN | 0022-3042 |
IngestDate | Fri Aug 16 10:01:46 EDT 2024 Fri Aug 23 00:30:10 EDT 2024 Thu Nov 24 18:22:06 EST 2022 Sat Aug 24 00:53:54 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Neurotrophin Immunopathology Rat Rodentia Retroviridae AIDS Immune deficiency Lentivirus Infection Virus Vertebrata Mammalia Viral disease Animal Transcription factor NFκB Human immunodeficiency virus Mechanism of action Apoptosis Dementia |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4217-9f0d7114deeccbe9fc89ecb6b4b93f6f51d1fcacdaaba800eb3fded99532ed4c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://doi.org/10.1046/j.1471-4159.2001.00467.x |
PQID | 18197079 |
PQPubID | 23462 |
PageCount | 16 |
ParticipantIDs | proquest_miscellaneous_18197079 crossref_primary_10_1046_j_1471_4159_2001_00467_x pascalfrancis_primary_14120672 wiley_primary_10_1046_j_1471_4159_2001_00467_x_JNC467 |
PublicationCentury | 2000 |
PublicationDate | 2001-08-01 |
PublicationDateYYYYMMDD | 2001-08-01 |
PublicationDate_xml | – month: 08 year: 2001 text: 2001-08-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford |
PublicationTitle | Journal of neurochemistry |
PublicationYear | 2001 |
Publisher | Blackwell Science Ltd Blackwell |
Publisher_xml | – name: Blackwell Science Ltd – name: Blackwell |
References | 1998; 281 2000; 6 2000; 47 1995; 37 1997; 275 1997; 47 1999; 286 1998; 82 1995; 375 1998; 154 1997; 8 1998; 273 1998; 16 1998; 18 2000; 18 1993; 73 2001 1999; 19 1999; 14 1997; 17 1999; 96 2000; 165 1998; 95 1998; 54 1993; 259 1994; 198 1997; 139 1997; 20 1995; 15 1995; 14 1999; 27 1986; 19 2000; 275 1996; 13 1992; 32 1995; 270 1995; 192 1995; 42 1994; 205 2000; 148 2000; 30 2000; 74 1993; 52 1992; 258 2000; 75 1996; 272 1999; 274 1994; 13 1995; 267 1996; 274 1999; 73 1994; 91 1989; 17 2001; 76 e_1_2_7_5_1 e_1_2_7_3_1 Sastry K. J. (e_1_2_7_53_1) 1996; 13 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_60_1 e_1_2_7_17_1 e_1_2_7_62_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_64_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_66_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_68_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_49_1 e_1_2_7_28_1 e_1_2_7_50_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_52_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_54_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_56_1 e_1_2_7_37_1 e_1_2_7_58_1 e_1_2_7_39_1 e_1_2_7_6_1 e_1_2_7_4_1 e_1_2_7_8_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_61_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_63_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_65_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_67_1 e_1_2_7_48_1 e_1_2_7_69_1 e_1_2_7_27_1 e_1_2_7_29_1 Courtney M. J. (e_1_2_7_9_1) 1997; 17 e_1_2_7_51_1 e_1_2_7_70_1 e_1_2_7_30_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_55_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_57_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_59_1 e_1_2_7_38_1 |
References_xml | – volume: 47 start-page: 155 year: 1997 end-page: 162 article-title: Inhibition of nuclear factor kappa B (NFkappaB) activity induces nerve growth factor‐resistant apoptosis in PC12 cells publication-title: J. Neurosci. Res. – volume: 30 start-page: 661 year: 2000 end-page: 670 article-title: T cell activation‐induced and HIV tat‐enhanced CD95 (APO‐1/Fas) ligand transcription involves NF‐kappaB publication-title: Eur. J. Immunol. – volume: 42 start-page: 34 year: 1995 end-page: 40 article-title: Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49–58 basic domain publication-title: J. Neurosci. Res. – volume: 75 start-page: 101 year: 2000 end-page: 108 article-title: Nuclear factor‐kappaB mediates the cell survival‐promoting action of activity‐dependent neurotrophic factor peptide‐9 publication-title: J. Neurochem. – volume: 17 start-page: 6419 year: 1989 article-title: Rapid detection of octamer binding proteins with ‘mini‐extracts’, prepared from a small number of cells publication-title: Nucleic Acids Res. – volume: 281 start-page: 1680 year: 1998 end-page: 1683 article-title: NF‐kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c‐IAP1 and c‐IAP2 to suppress caspase‐8 activation publication-title: Science – volume: 259 start-page: 1912 year: 1993 end-page: 1915 article-title: NF‐kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway publication-title: Science – year: 2001 – volume: 19 start-page: 525 year: 1986 end-page: 535 article-title: The AIDS dementia complex: II. Neuropathology publication-title: Ann. Neurol. – volume: 96 start-page: 857 year: 1999 end-page: 868 article-title: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor publication-title: Cell – volume: 14 start-page: 28 year: 1999 end-page: 40 article-title: p75‐mediated NF‐kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor publication-title: Mol. Cell. Neurosci. – volume: 286 start-page: 2358 year: 1999 end-page: 2361 article-title: Mediation by a CREB family transcription factor of NGF‐dependent survival of sympathetic neurons publication-title: Science – volume: 375 start-page: 497 year: 1995 end-page: 500 article-title: Sensitization of T cells to CD95‐mediated apoptosis by HIV‐1 Tat and gp120 publication-title: Nature – volume: 19 start-page: 8856 year: 1999 end-page: 8865 article-title: Lack of the p50 subunit of nuclear factor‐kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury publication-title: J. Neurosci. – volume: 281 start-page: 998 year: 1998 end-page: 1001 article-title: IEX‐1L, an apoptosis inhibitor involved in NF‐kappaB‐mediated cell survival publication-title: Science – volume: 73 start-page: 295 year: 1993 end-page: 307 article-title: The proto‐oncogene bcl‐2 can selectively rescue neurotrophic factor‐dependent neurons from apoptosis publication-title: Cell – volume: 75 start-page: 1377 year: 2000 end-page: 1389 article-title: Identification and characterization of nuclear factor kappaB binding sites in the murine bcl‐x promoter publication-title: J. Neurochem. – volume: 82 start-page: 97 year: 1998 end-page: 106 article-title: Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein publication-title: Neuroscience – volume: 16 start-page: 395 year: 1998 end-page: 419 article-title: BCL‐2 family: regulators of cell death publication-title: Annu. Rev. Immunol. – volume: 18 start-page: 455 year: 2000 end-page: 468 article-title: NGF‐mediated alteration of NF‐kappaB binding activity after partial immunolesions to rat cholinergic basal forebrain neurons publication-title: Int. J. Dev. Neurosci. – volume: 95 start-page: 2509 year: 1998 end-page: 2514 article-title: A simplified system for generating recombinant adenoviruses publication-title: Proc. Natl. Acad. Sci. USA – volume: 73 start-page: 578 year: 1999 end-page: 586 article-title: HIV‐1 Tat‐mediated activation of glycogen synthase kinase‐3beta contributes to Tat‐mediated neurotoxicity publication-title: J. Neurochem. – volume: 275 start-page: 661 year: 1997 end-page: 665 article-title: Regulation of neuronal survival by the serine‐threonine protein kinase Akt publication-title: Science – volume: 139 start-page: 809 year: 1997 end-page: 815 article-title: Activated phosphatidylinositol 3‐kinase and Akt kinase promote survival of superior cervical neurons publication-title: J. Cell. Biol. – volume: 13 start-page: 1017 year: 1994 end-page: 1030 article-title: Overexpression of BCL‐2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia publication-title: Neuron – volume: 18 start-page: 10356 year: 1998 end-page: 10365 article-title: Nerve growth factor‐dependent activation of NF‐kappaB contributes to survival of sympathetic neurons publication-title: J. Neurosci. – volume: 32 start-page: 11 year: 1992 end-page: 17 article-title: Human immunodeficiency virus type 1‐infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesion publication-title: Ann. Neurol. – volume: 91 start-page: 3309 year: 1994 end-page: 3313 article-title: Neonatal motoneurons overexpressing the bcl‐2 protooncogene in transgenic mice are protected from axotomy‐induced cell death publication-title: Proc. Natl. Acad. Sci. USA – volume: 274 start-page: 8531 year: 1999 end-page: 8538 article-title: Tumor necrosis factor induces Bcl‐2 and Bcl‐x expression through NFkappaB activation in primary hippocampal neurons publication-title: J. Biol. Chem. – volume: 17 start-page: 4201 year: 1997 end-page: 4211 article-title: Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two‐component mechanism publication-title: J. Neurosci. – volume: 54 start-page: 798 year: 1998 end-page: 804 article-title: Beta‐amyloid binds to p75NTR and activates NFkappaB in human neuroblastoma cells publication-title: J. Neurosci. Res. – volume: 270 start-page: 1326 year: 1995 end-page: 1331 article-title: Opposing effects of ERK and JNK‐p38 MAP kinases on apoptosis publication-title: Science – volume: 198 start-page: 234 year: 1994 end-page: 244 article-title: HIV‐1 induces down‐regulation of bcl‐2 expression and death by apoptosis of EBV‐immortalized B cells: a model for a persistent ‘self‐limiting’ HIV‐1 infection publication-title: Virology – volume: 148 start-page: 325 year: 2000 end-page: 332 article-title: Cytokine‐induced nuclear factor kappa B activation promotes the survival of developing neurons publication-title: J. Cell. Biol. – volume: 273 start-page: 17852 year: 1998 end-page: 17858 article-title: HIV‐1 Tat induces neuronal death via tumor necrosis factor‐alpha and activation of non‐ ‐methyl‐d‐aspartate receptors by a NFkappaB‐independent mechanism publication-title: J. Biol. Chem. – volume: 76 start-page: 312 year: 2001 end-page: 315 article-title: Heregulin upregulates the expression of nitric oxide synthase (NOS)‐1 in rat cerebellar granule neurons via the ErbB4 receptor publication-title: J. Neurochem. – volume: 14 start-page: 2876 year: 1995 end-page: 2883 article-title: Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli publication-title: EMBO J. – volume: 274 start-page: 22569 year: 1999 end-page: 22580 article-title: Neuroprotection by brain‐derived neurotrophic factor is mediated by extracellular signal‐regulated kinase and phosphatidylinositol 3‐kinase publication-title: J. Biol. Chem. – volume: 19 start-page: 5923 year: 1999 end-page: 5929 article-title: NF‐kappaB induces expression of the Bcl‐2 homologue A1/Bfl‐1 to preferentially suppress chemotherapy‐induced apoptosis publication-title: Mol. Cell. Biol. – volume: 275 start-page: 1132 year: 1997 end-page: 1136 article-title: The release of cytochrome c from mitochondria: a primary site for Bcl‐2 regulation of apoptosis publication-title: Science – volume: 73 start-page: 2341 year: 1999 end-page: 2347 article-title: Activity‐dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress‐induced death publication-title: J. Neurochem. – volume: 74 start-page: 527 year: 2000 end-page: 539 article-title: Functional interplay between nuclear factor‐kappaB and c‐Jun integrated by coactivator p300 determines the survival of nerve growth factor‐dependent PC12 cells publication-title: J. Neurochem. – volume: 16 start-page: 225 year: 1998 end-page: 260 article-title: NF‐kappa B and Rel proteins: evolutionarily conserved mediators of immune responses publication-title: Annu. Rev. Immunol. – volume: 275 start-page: 1129 year: 1997 end-page: 1132 article-title: Prevention of apoptosis by Bcl‐2: release of cytochrome c from mitochondria blocked publication-title: Science – volume: 27 start-page: 2086 year: 1999 end-page: 2090 article-title: Activation of the Bcl‐2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade publication-title: Nucleic Acids Res. – volume: 54 start-page: 465 year: 1998 end-page: 474 article-title: NGF induces apoptosis in a human neuroblastoma cell line expressing the neurotrophin receptor p75NTR publication-title: J. Neurosci. Res. – volume: 37 start-page: 373 year: 1995 end-page: 380 article-title: Human immunodeficiency virus type 1 tat activates non‐ ‐methyl‐d‐aspartate excitatory amino acid receptors and causes neurotoxicity publication-title: Ann. Neurol. – volume: 47 start-page: 186 year: 2000 end-page: 194 article-title: Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine publication-title: Ann. Neurol. – volume: 154 start-page: 276 year: 1998 end-page: 288 article-title: HIV‐1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress publication-title: Exp. Neurol. – volume: 19 start-page: 129 year: 1999 end-page: 150 article-title: Human immunodeficiency virus‐associated dementia publication-title: Semin. Neurol. – volume: 205 start-page: 519 year: 1994 end-page: 529 article-title: The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines publication-title: Virology – volume: 8 start-page: 2937 year: 1997 end-page: 2942 article-title: Reduced nuclear factor kappaB (p65) expression in rat primary sensory neurons after peripheral nerve injury publication-title: Neuroreport – volume: 18 start-page: 2933 year: 1998 end-page: 2943 article-title: Phosphatidylinositol 3‐kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor‐dependent sympathetic neurons publication-title: J. Neurosci. – volume: 274 start-page: 9828 year: 1999 end-page: 9835 article-title: Insulin‐like growth factor‐1‐mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB publication-title: J. Biol. Chem. – volume: 274 start-page: 782 year: 1996 end-page: 784 article-title: An essential role for NF‐kappaB in preventing TNF‐alpha‐induced cell death publication-title: Science – volume: 20 start-page: 287 year: 1997 end-page: 290 article-title: p75NTR and apoptosis: Trk‐dependent and Trk‐independent effects publication-title: Trends Neurosci. – volume: 275 start-page: 34021 year: 2000 end-page: 34024 article-title: The NF‐kappa B‐inducing kinase induces PC12 cell differentiation and prevents apoptosis publication-title: J. Biol. Chem. – volume: 258 start-page: 302 year: 1992 end-page: 304 article-title: Prevention of programmed cell death of sympathetic neurons by the bcl‐2 proto‐oncogene publication-title: Science – volume: 15 start-page: 2359 year: 1995 end-page: 2366 article-title: Tumor necrosis factor alpha‐induced apoptosis in human neuronal cells: protection by the antioxidant ‐acetylcysteine and the genes bcl‐2 and crmA publication-title: Mol. Cell. Biol. – volume: 272 start-page: 542 year: 1996 end-page: 545 article-title: Selective activation of NF‐kappa B by nerve growth factor through the neurotrophin receptor p75 publication-title: Science – volume: 165 start-page: 1743 year: 2000 end-page: 1754 article-title: The NF‐kappa B cascade is important in Bcl‐xL expression and for the anti‐apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes publication-title: J. Immunol. – volume: 73 start-page: 1363 year: 1999 end-page: 1374 article-title: Involvement of inositol 1,4,5‐trisphosphate‐regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV‐1 protein tat publication-title: J. Neurochem. – volume: 267 start-page: 2003 year: 1995 end-page: 2006 article-title: Requirement for phosphatidylinositol‐3 kinase in the prevention of apoptosis by nerve growth factor publication-title: Science – volume: 275 start-page: 7558 year: 2000 end-page: 7565 article-title: Nerve growth factor activation of nuclear factor kappaB through its p75 receptor is an anti‐apoptotic signal in RN22 schwannoma cells publication-title: J. Biol. Chem. – volume: 6 start-page: 1380 year: 2000 end-page: 1387 article-title: Uptake of HIV‐1 tat protein mediated by low‐density lipoprotein receptor‐related protein disrupts the neuronal metabolic balance of the receptor ligands publication-title: Nat. Med. – volume: 13 start-page: 487 year: 1996 end-page: 493 article-title: Expression of human immunodeficiency virus type I tat results in down‐regulation of bcl‐2 and induction of apoptosis in hematopoietic cells publication-title: Oncogene – volume: 52 start-page: 561 year: 1993 end-page: 566 article-title: A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia publication-title: J. Neuropathol. Exp. Neurol. – volume: 20 start-page: 245 year: 1997 end-page: 267 article-title: Bcl‐2 gene family in the nervous system publication-title: Annu. Rev. Neurosci. – volume: 192 start-page: 41 year: 1995 end-page: 44 article-title: Regulation of NF‐kappa B activity in rat dorsal root ganglia and PC12 cells by tumour necrosis factor and nerve growth factor publication-title: Neurosci. Lett. – ident: e_1_2_7_4_1 doi: 10.1016/S0166-2236(96)01049-1 – ident: e_1_2_7_42_1 doi: 10.1002/ana.410370314 – ident: e_1_2_7_14_1 doi: 10.1073/pnas.91.8.3309 – ident: e_1_2_7_12_1 doi: 10.1074/jbc.M010499200 – ident: e_1_2_7_55_1 doi: 10.1126/science.8096091 – ident: e_1_2_7_23_1 doi: 10.1046/j.1471-4159.2000.0750101.x – ident: e_1_2_7_30_1 doi: 10.4049/jimmunol.165.4.1743 – ident: e_1_2_7_46_1 doi: 10.1083/jcb.148.2.325 – ident: e_1_2_7_32_1 doi: 10.1046/j.1471-4159.2001.00089.x – ident: e_1_2_7_54_1 doi: 10.1093/nar/17.15.6419 – ident: e_1_2_7_2_1 doi: 10.1016/0092-8674(93)90230-N – ident: e_1_2_7_36_1 doi: 10.1093/nar/27.10.2086 – ident: e_1_2_7_6_1 doi: 10.1126/science.272.5261.542 – ident: e_1_2_7_26_1 doi: 10.1046/j.1471-4159.1999.0731363.x – ident: e_1_2_7_56_1 doi: 10.1002/(SICI)1097-4547(19970115)47:2<155::AID-JNR4>3.0.CO;2-E – ident: e_1_2_7_47_1 doi: 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.0.CO;2-3 – ident: e_1_2_7_19_1 doi: 10.1074/jbc.275.11.7558 – ident: e_1_2_7_34_1 doi: 10.1002/(SICI)1097-4547(19981115)54:4<465::AID-JNR4>3.0.CO;2-T – ident: e_1_2_7_7_1 doi: 10.1146/annurev.immunol.16.1.395 – ident: e_1_2_7_21_1 doi: 10.1046/j.1471-4159.2000.0751377.x – ident: e_1_2_7_43_1 doi: 10.1016/0896-6273(94)90266-6 – ident: e_1_2_7_29_1 doi: 10.1074/jbc.274.32.22569 – ident: e_1_2_7_49_1 doi: 10.1074/jbc.273.28.17852 – ident: e_1_2_7_51_1 doi: 10.1083/jcb.139.3.809 – ident: e_1_2_7_24_1 doi: 10.1016/S0736-5748(00)00004-6 – ident: e_1_2_7_27_1 doi: 10.1073/pnas.95.5.2509 – ident: e_1_2_7_22_1 doi: 10.1046/j.1471-4159.1999.0732341.x – ident: e_1_2_7_69_1 doi: 10.1126/science.7701324 – ident: e_1_2_7_15_1 doi: 10.1046/j.1471-4159.2002.00831.x – ident: e_1_2_7_68_1 doi: 10.1126/science.275.5303.1129 – ident: e_1_2_7_10_1 doi: 10.1523/JNEUROSCI.18-08-02933.1998 – ident: e_1_2_7_39_1 doi: 10.1523/JNEUROSCI.18-24-10356.1998 – ident: e_1_2_7_52_1 doi: 10.1126/science.286.5448.2358 – ident: e_1_2_7_57_1 doi: 10.1128/MCB.15.5.2359 – ident: e_1_2_7_60_1 doi: 10.1002/j.1460-2075.1995.tb07287.x – ident: e_1_2_7_41_1 doi: 10.1046/j.1471-4159.2000.740527.x – ident: e_1_2_7_28_1 doi: 10.1074/jbc.274.14.9828 – ident: e_1_2_7_40_1 doi: 10.1046/j.1471-4159.1999.0730578.x – ident: e_1_2_7_58_1 doi: 10.1074/jbc.274.13.8531 – ident: e_1_2_7_61_1 doi: 10.1126/science.281.5383.1680 – ident: e_1_2_7_25_1 doi: 10.1006/mcne.1999.0770 – ident: e_1_2_7_33_1 doi: 10.1006/exnr.1998.6958 – ident: e_1_2_7_38_1 doi: 10.1002/1521-4141(200002)30:2<661::AID-IMMU661>3.0.CO;2-L – ident: e_1_2_7_65_1 doi: 10.1016/0304-3940(95)11603-T – ident: e_1_2_7_37_1 doi: 10.1038/82199 – ident: e_1_2_7_45_1 doi: 10.1146/annurev.neuro.20.1.245 – ident: e_1_2_7_64_1 doi: 10.1038/375497a0 – ident: e_1_2_7_59_1 doi: 10.1002/ana.410320104 – ident: e_1_2_7_13_1 doi: 10.1097/00001756-199709080-00026 – ident: e_1_2_7_16_1 doi: 10.1097/00005072-199311000-00002 – ident: e_1_2_7_66_1 doi: 10.1126/science.281.5379.998 – ident: e_1_2_7_18_1 doi: 10.1126/science.1411528 – ident: e_1_2_7_70_1 doi: 10.1523/JNEUROSCI.19-20-08856.1999 – ident: e_1_2_7_63_1 doi: 10.1002/jnr.490420105 – ident: e_1_2_7_17_1 doi: 10.1074/jbc.C000507200 – ident: e_1_2_7_11_1 doi: 10.1006/viro.1994.1026 – ident: e_1_2_7_31_1 doi: 10.1126/science.275.5303.1132 – ident: e_1_2_7_35_1 doi: 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.0.CO;2-T – ident: e_1_2_7_20_1 doi: 10.1146/annurev.immunol.16.1.225 – ident: e_1_2_7_62_1 doi: 10.1128/MCB.19.9.5923 – ident: e_1_2_7_48_1 doi: 10.1002/ana.410190603 – ident: e_1_2_7_8_1 doi: 10.1016/S0306-4522(97)00174-7 – ident: e_1_2_7_3_1 doi: 10.1126/science.274.5288.782 – ident: e_1_2_7_5_1 doi: 10.1016/S0092-8674(00)80595-4 – ident: e_1_2_7_50_1 doi: 10.1006/viro.1994.1673 – ident: e_1_2_7_67_1 doi: 10.1126/science.270.5240.1326 – ident: e_1_2_7_44_1 doi: 10.1055/s-2008-1040831 – volume: 17 start-page: 4201 year: 1997 ident: e_1_2_7_9_1 article-title: Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two‐component mechanism publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.17-11-04201.1997 contributor: fullname: Courtney M. J. – volume: 13 start-page: 487 year: 1996 ident: e_1_2_7_53_1 article-title: Expression of human immunodeficiency virus type I tat results in down‐regulation of bcl‐2 and induction of apoptosis in hematopoietic cells publication-title: Oncogene contributor: fullname: Sastry K. J. |
SSID | ssj0016461 |
Score | 2.022565 |
Snippet | HIV‐1 associated dementia is thought to be caused by neuronal damage and death in response to the production of soluble neurotoxic factors by virally infected... HIV-1 associated dementia is thought to be caused by neuronal damage and death in response to the production of soluble neurotoxic factors by virally infected... |
SourceID | proquest crossref pascalfrancis wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 874 |
SubjectTerms | apoptosis Bcl‐2 Biological and medical sciences Human immunodeficiency virus 1 human immunodeficiency virus type 1 Human viral diseases Infectious diseases Medical sciences neurotrophic factors nuclear factor‐κB Tat Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
Title | Neurotrophins prevent HIV Tat‐induced neuronal apoptosis via a nuclear factor‐κB (NF‐κB)‐dependent mechanism |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1471-4159.2001.00467.x https://search.proquest.com/docview/18197079 |
Volume | 78 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Bb9MwFLamXTYJwdhAlMHwAaFxSFU3TlIfR0fXTaKHaUO9RXZsa9HUJGrSaXDiJ_B7-BH8CH7J3rObQicOCO2S-BDH8vN79vfs5-8R8pZJHjPLeKCFiQIeGhaIQU8HJlNhlDAleu4i7adJPL7kZ9Nouox_wrswnh9iteGGluHmazRwqXwWkp5jt0UjT8D_gfUY3TzWRVcv6SKeZGGC0V3H5ysmKWTRYivicFDUZVBPe8D5tx-trVSPKlmD0KzPdrEGR_8EtW5VGj0h121_fDDKdXfRqG729R7V48N0eIc8XoJXeuS17SnZMMUu2TsqwHGffaHvqAsndfv0u2Rr2KaS2yM3jgKkmZfVVV7UtPK0UXR8-pleyObXt-95oUHFNHXsmtiErMqqKeu8pje5pJIWSLss59SnB4IaP398oIeTkS-9h1ebzbehM4O3mfN69oxcjj5eDMfBMuFDkHFwjQJhezoBB00bUCxlhM0GApQmVlyJ0MY2YprZTGZaSiUB6RoVWm20EFHYN5pn4XOyWZSFeQGDC9_LAcA5gCOggVoOtEoi07cwRcEKHHUIawc3rTyvR-rO43ns_KGEpShozNLJUifo9LZDDta04HdFzpAFv98hb1q1SEHCePQiC1Mu6hRwlEAuwg6J3BD_c5vp2WQIhZf_WW-fbPugOYxYfEU2m_nCvAYU1agDZx_wPJmyO9jMFw4 |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Bb9MwFLamcRgSAraB1g02HxCCQ0rdOEl9HGVVN7YeUId2s-zY1qLRJGrSCXbaT-D38CP4EfwSnu2ko4gDQpzsQxzL9nt-37Ofv4fQCyJoTAyhgWI6CmioScAGPRXoVIZRQiTruYe0Z5N4fE5PLqKLJh2QfQvj-SGWB25WM9x-bRXcHki_aa4lGy1PwAECg2z9PNK1vl7SBUB5D8rQ5nF492HJJWV5tMiSOhxEtQnraa84__SnFVv1oBQVTJvx-S5WAOmvsNbZpdEj9KkdkQ9HueouatlNb34je_xPQ36MHjb4FR96gdtEazrfQtuHOfjusy_4JXYRpe6ofgttDNtsctvo2rGA1POivMzyCpeeOQqPjz_iqah_3H7NcgVSprAj2LRdiLIo66LKKnydCSxwbpmXxRz7DEHQ4vu3t_jVZORrr6FoE_rWeKbtg-asmj1B56Oj6XAcNDkfgpSCdxQw01MJ-GhKg2xJzUw6YCA3saSShSY2EVHEpCJVQkgBYFfL0CitGIvCvlY0DZ-i9bzI9Q6sLnwvBoDoAJGAECoxUDKJdN_ALgVGOOog0q4uLz21B3dX8jR2LlFCuJ1om6iTcDfR_HMH7a-IwV1DSiwRfr-DDlq54DDD9vZF5LpYVBygFLN0hB0UuTX-6z75yWQIld1_bHeANsbTs1N-ejx5v4fu-xg6G8D4DK3X84V-DqCqlvtOWX4CkYcaNQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELaqIgFSRaEFsf31ASE4ZFlvnGR9bBdW2wIrhFrUm2XHtoiqTaJNtoKeeASepw_Rh-iTdGwnWxZxQIhTfIhjZTxjf-MZf4PQCyJoTAyhgWI6CmioScAGPRXoVIZRQiTruYu0Hyfx-JQen0VnTf6TvQvj-SEWB27WMtx6bQ28VOZNE5VsjDwB_wf2Y-vmka519ZIu4Ml7NAYgbAHS5wWVlKXRIgvmcNDUJqunjXD-6UtLW9VaKSqQmvHlLpbw6K-o1m1Lo3V03v6Qz0Y5785r2U0vf-N6_D9__Bg9atArPvDq9gSt6HwDbR7k4LlPv-OX2OWTuoP6DfRg2NaS20QXjgOknhXl1yyvcOl5o_D46As-EfXNj59ZrkDHFHb0mnYIURZlXVRZhS8ygQXOLe-ymGFfHwh6XF8d4leTkW-9hkdbzrfGU22vM2fV9Ck6Hb07GY6DpuJDkFLwjQJmeioBD01p0CypmUkHDLQmllSy0MQmIoqYVKRKCCkA6moZGqUVY1HY14qm4TO0mhe5fg6TC--LAeA5wCOggkoMlEwi3TewRsEWHHUQaSeXl57Yg7uAPI2dQ5QQbgVty3QS7gTNv3XQ3pIW3HWkxNLg9ztov1ULDhK2sReR62JecQBSzJIRdlDkpvivx-THkyE0tv6x3z66_-ntiH84mrzfRg99Ap3NXtxBq_VsrncBUdVyz5nKLTXXGOQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neurotrophins+prevent+HIV+Tat%E2%80%90induced+neuronal+apoptosis+via+a+nuclear+factor%E2%80%90%CE%BAB+%28NF%E2%80%90%CE%BAB%29%E2%80%90dependent+mechanism&rft.jtitle=Journal+of+neurochemistry&rft.au=Ramirez%2C+Servio+H.&rft.au=Sanchez%2C+Joseph+F.&rft.au=Dimitri%2C+Christopher+A.&rft.au=Gelbard%2C+Harris+A.&rft.date=2001-08-01&rft.pub=Blackwell+Science+Ltd&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=78&rft.issue=4&rft.spage=874&rft.epage=889&rft_id=info:doi/10.1046%2Fj.1471-4159.2001.00467.x&rft.externalDBID=10.1046%252Fj.1471-4159.2001.00467.x&rft.externalDocID=JNC467 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon |